Your browser does not support JavaScript!

FranceBiotechnologies

FranceBiotechnologies est une plateforme pour découvrir les actualités, entreprises, produits et savoir-faire techniques de la biotechnologies. Partagez et échangez entre spécialistes.

Rejoignez la communauté
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

Novo bags rights to UBE's preclinical NASH prospect

Il y a 5 jours
Novo Nordisk has picked up global rights to a preclinical nonalcoholic steatohepatitis candidate from UBE Industries. The deal gives Novo control of UD-014, a small-molecule inhibitor of...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Here’s Why Bad Data Management Can Destroy Your Company

Il y a 6 jours
Did you know that companies lose up to $15M every year due to poor data management? And this number will grow steadily as the amount of data generated worldwide increases too. By 2025, the total...
www.labiotech.eu
Une actualité de L'Usine Nouvelle a été ajouté(e)
Il y a 4 jours

Les start-up en quête de fonds

Il y a 5 jours
La 12e édition des Rendez-vous Carnot, qui s’est tenue à Paris les 16 et 17 octobre, a mis à l’honneur la santé. Les start-up du secteur... - Pharmacie / Biotechnologies
www.usinenouvelle.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

FTC orders artificial limb maker Ottobock to undo and divest its knee acquisition

Il y a 5 jours
After two years, the Federal Trade Commission has ordered the German prosthetics company Ottobock to roll back its acquisition of Freedom Innovations, saying the merger of the two manufacturers would...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

EuroBiotech: More Articles of Note

Il y a 5 jours
In our EuroBiotech roundup this week, Enterome teams up with MSK, 4D posts Keytruda combination data and Artios licenses MD Anderson drug....
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

€51M Nasdaq IPO Will Fund Centogene’s Rare Disease Diagnostics

Il y a 5 jours
The German company Centogene has raised €50.6M ($56M) in an IPO on the Nasdaq Stock Exchange to fund the development of diagnostics technology that could improve the treatment of rare diseases. The...
www.labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

ASH: UPenn’s CRISPR-edited immune cells prove safe in small cancer study

Il y a 5 jours
Three years after tech billionaire Sean Parker's Institute for Cancer Immunotherapy became the first research institution to launch a human trial of CRISPR-edited cells in cancer, the scientists...
www.fiercebiotech.com
Une actualité de Labiotech.eu a été ajouté(e)
Il y a 4 jours

Avantium Builds 10-Ton Demonstration Plant to Produce Bioplastics

Il y a 5 jours
The Dutch bioplastics company Avantium has opened a demonstration plant capable of producing 10 tons per year of mono-ethylene glycol (MEG), a compound used to make plastics, using plants as the...
www.labiotech.eu
Une actualité de FierceBiotech a été ajouté(e)
Il y a 4 jours

FDA revamps office that reviews cancer treatments

Il y a 5 jours
In a bid to streamline the review of new treatments for cancer, the FDA has reorganized and renamed the Office of Hematology and Oncology Products (OHOP). Pazdur, M.D., who led the former OHOP, will...
www.fiercebiotech.com
Une actualité de FierceBiotech a été ajouté(e)
Il y a 5 jours

Vifor commits €25M to nephrology R&D joint venture with Evotec

Il y a 6 jours
Vifor Pharma has committed €25 million ($28 million) to a nephrology joint venture with Evotec. The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint...
www.fiercebiotech.com
Charger plus d'actualités